Date Published:
2018 08

Publication Type:
Journal Article

Authors:

I.M. Elicer
D. Byrd
U.S. Clark
S. Morgello
J. Robinson-Papp

Secondary:
J Neurovirol

Volume:
24

Pagination:
514-522

Issue:
4

PMID:
29696578

URL:
https://pubmed.ncbi.nlm.nih.gov/29696578

DOI:
10.1007/s13365-018-0640-6

Keywords:
Adult;Aged;AIDS Dementia Complex;Cerebrovascular Disorders;Comorbidity;Female;Humans;Male;Middle Aged;Motor Activity;Motor Disorders;neurocognitive disorders;Neuropsychological Tests;Prevalence

Abstract:
<p>HIV-associated neurocognitive disorders (HAND) remain prevalent in the combined antiretroviral therapy (CART) era, especially the milder forms. Despite these milder phenotypes, we have shown that motor abnormalities persist and have quantified them with the HIV Dementia Motor Scale (HDMS). Our objectives were to replicate, in an independent sample, our prior findings that the HDMS is associated with cognitive impairment in HIV, while adding consideration of age-associated comorbidities such as cerebrovascular disease, and to examine the longitudinal trajectories of cognitive and motor dysfunction. We included all participants enrolled in the Manhattan HIV Brain Bank (MHBB) from January 2007 to May 2017 who had complete baseline data (N = 164). MHBB participants undergo standardized longitudinal assessments including documentation of comorbidities and medications, blood work, the HDMS, and neurocognitive testing. We found that motor dysfunction, cognitive impairment, and cerebrovascular disease were significantly associated with each other at baseline. Cerebrovascular disease independently predicted cognitive impairment in a multivariable model. Longitudinal analysis in a subset of 78 participants with ≥ 4 years of follow-up showed a stable cognition but declining motor function. We conclude that the HDMS is a valid measurement of motor dysfunction in HIV-infected patients and is associated with cognitive impairment and the presence of cerebrovascular disease. Cognitive impairment is mild and stable in CART-treated HIV; however, motor function declines over time, which may be related to the accrual of comorbidities such as cerebrovascular disease. Further research should examine the mechanisms underlying motor dysfunction in HIV and its clinical impact.</p>